‘Obesity is at a crisis point’: Study predicts that 260 million in US will be overweight or obese by 2050
In a little over two decades, almost 260 million people in the United States are predicted to have overweight or obesity, ...
MedPage Today on MSN3d
ObesityWeek Roundup: Patients More Likely to Ration Weight-Loss Drugs
SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...
Medindia5d
Obesity News
and management of obesity. It covers topics like healthy eating, exercise, medical interventions, and policy initiatives aimed at combating the global obesity epidemic.
Medicaid covers GLP-1 meds for obesity in just 13 states, analysis finds
Poorer folks' access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found. Only 13 ...
UPI10d
Medicaid covers GLP-1 weight-loss drugs in just 13 states
Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers discovered. Advertisement Under the Medicaid system ...
U.S. News & World Report10d
Medicaid Covers GLP-1 Meds for Obesity in Just 13 States
Medicaid Covers GLP-1 Meds for Obesity in Just 13 States By Dennis Thompson HealthDay Reporter TUESDAY, Nov. 5, 2024 (HealthDay News) -- Low-income patients' access to blockbuster weight-loss ...
HealthDay on MSN9d
Medicaid covers GLP-1 weight-loss drugs in just 13 states
Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) ...
KTEN10d
Medicaid Covers GLP-1 Meds for Obesity in Just 13 States
Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers discovered. Among those states that don’t cover the ...